Those taking tirzepatide, managed an additional 5.5% WL from randomisation, compared to those taking placebo who experienced mean weight regain of 14% from randomisation [49]
The oral version is typically recommended for gut health and systemic inflammation , while the injectable form may be used for more targeted tissue and injury repair
"The discovery and development of liraglutide and semaglutide." Frontiers in Endocrinology , 10, 155
Getting the right dose matters for both safety and effectiveness
This can be applied to MS patients that are constantly or intermittently suffering from tissue damage
And the doctor who prescribed it would refute the lack of data, saying the absence of evidence is not evidence of absence, and that his patients are deriving substantial benefit without side effects